🇺🇸 FDA
Patent

US 8153156

Hydrogel nanocompsites for ophthalmic applications

granted A61KA61K31/785A61K9/0048

Quick answer

US patent 8153156 (Hydrogel nanocompsites for ophthalmic applications) held by The United States of America as represented by the Department of Veteran Affairs expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Department of Veteran Affairs
Grant date
Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/785, A61K9/0048, A61K9/5138, A61K9/5192